Clinical trialNCT03880396CompletedObservational

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

SponsorAssiut UniversityEnrollment62Squamous Cell Carcinoma of the Head and Neck

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary endpoint will be acute toxicity. Secondary endpoints included: late toxicity and quality of life; loco-regional control, disease free survival and overall survival.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Aiat M Mohammed, Doctor
Assiut University
Principal Investigator
clinicaltrials.gov ↗
Doaa G Abdelnaser Fathy Mahmoud, Doctor
Assiut University
Principal Investigator
clinicaltrials.gov ↗
Hoda H Essa, Doctor
Assiut University
Principal Investigator
clinicaltrials.gov ↗
Mohamed O Gad, Doctor
Assiut University
Principal Investigator
clinicaltrials.gov ↗
Nora Essam
South Egypt Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Egypt

Assiut University
Asyut, Egypt

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Mar 2019
Primary completion: 26 Dec 2020
Completion: 26 Dec 2020
Last update posted: 26 Jul 2022
Registered enrollment: 62
Registry id: NCT03880396

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.